Skip to content

13F-HR filed by Iron Triangle Partners LP

Iron Triangle Partners LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 27 holding rows worth $572,018,000.

Accession
0001172661-22-002382
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 27 entries on the cover page, a total value of $572,018,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $572,018,000 with VALUE read as thousands by filing date, 13F file number 028-20024. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHARLES RIV LABS INTL INC159864107COM202,000$39,754,000thousands by filing date
Cigna Corporation125523100COM143,010$39,681,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM355,601$37,768,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR900,000$34,218,000thousands by filing date
HEALTHEQUITY INC COM42226A107Stock440,000$29,555,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock350,000$27,363,000thousands by filing date
Boston Scientific Corporation101137107COM700,000$27,111,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock487,193$26,226,000thousands by filing date
HCA Healthcare Inc40412C101COM140,000$25,731,000thousands by filing date
INARI MED INC45332Y109COM300,000$21,792,000thousands by filing date
BIO RAD LABS INC090572207CL A50,000$20,857,000thousands by filing date
REPLIGEN CORP COM759916109Stock100,000$18,711,000thousands by filing date
INSULET CORP COM45784P101Stock80,000$18,352,000thousands by filing date
CATALENT INC USD 0.01148806102COM250,000$18,090,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock100,000$17,737,000thousands by filing date
ESTABLISHMENT LABS HOLDINGSG31249108COMMON STOCK322,278$17,600,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock3,000,000$17,415,000thousands by filing date
HUMANA INC COM444859102Stock35,000$16,982,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM150,000$16,581,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS265,076$16,406,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock80,000$16,013,000thousands by filing date
ICON PUB LTD CO SHSG4705A100Stock83,798$15,400,000thousands by filing date
908 DEVICES INC COM65443P102Stock900,000$14,805,000thousands by filing date
SURGERY PARTNERS INC86881A100COM550,000$12,870,000thousands by filing date
DEXCOM INC COM252131107Stock150,000$12,081,000thousands by filing date
ORION ACQUISITION CORP68626A207UNIT 02/19/2026999,513$9,865,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK1,696,599$3,054,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-22-002382this filing2022-11-14acceptance time not in the bulk data set